Johnson & Johnson (US)
Selected Johnson & Johnson advertising
Best-known for babycare and Band-Aids, Johnson & Johnson
has long been one of the world's biggest healthcare manufacturers, and got even bigger in 2006 with the purchase of the consumer
health division of Pfizer. In fact, consumer products had until then been the group's smallest
segment. The largest chunk of group revenues still comes from pharmaceuticals, including blockbusters such as Remicade, Procrit and Risperdal, and medical devices. The group flavours a highly decentralised structure with a broad portfolio of almost 200 separately branded
subsidiary businesses, operating as McNeil, Janssen, Depuy and Ethicon among many others. Key brands under the group's umbrella
include Tylenol, Neutrogena, Aveeno and Ortho
contraceptives, as well as medical devices, surgical products and Acuevue contact lenses. Despite its size, Johnson & Johnson has endured tough trading in recent years, especially in the US, as a result of a series of manufacturing problems and product recalls that have tainted the reputations
of several of its best-known consumer brands.
Adbrands Weekly Update 3rd Apr 2014:
One of Johnson & Johnson's top centralised marketers, Kim Kadlec, has resigned as VP, worldwide marketing to join AOL as head of relationships management.
Adbrands Weekly Update 13th Mar 2014:
Reckitt Benckiser acquired global rights to the K-Y "intimate lubricant" brand from Johnson & Johnson for a reported $240m. It will pair the brand with its existing Durex business, best-known worldwide for condoms, but which now has its own line of lubricants under the
Durex Play banner. K-Y currently generates around $100m a year in sales, almost 70% of which are generated in North America and Brazil. Johnson & Johnson will continue to manufacture all K-Y products under contract. RB has also been linked to a possible bid for Merck & Co's
OTC healthcare business, which includes US rights to the Scholl brand (which Reckitt controls in Europe), Coppertone suncare and other products.
Adbrands Weekly Update
3rd Feb 2014: Healthcare giant
Johnson & Johnson reported another year of record performance, boosted by strong pharma growth and the
acquisition of medical devices manufacturer Synthes. Revenues rose 6% to a best-ever $71.3bn, while net income jumped 27% to $13.8bn. The strongest growth came
from pharmaceuticals where sales jumped 11% to $28.1bn, catching up with the mammoth medical devices division at $28.5bn. There was also slow but steady recovery in the group's troubled consumer healthcare business, still trying to
recover ground lost in a series of US product calls. Overall global
consumer healthcare growth was under 2%, but the badly dented US OTC business outperformed with a very healthy 20% jump offset by declines in other units.
Adbrands Weekly Update 7th Nov 2013: Deutsch returned to the Johnson & Johnson roster, replacing IPG stablemate McCann on the Acuevue account.
Adbrands Weekly Update 7th Nov 2013:
Johnson & Johnson is to pay fines and settlements totaling $2.2bn to US regulators for off-label promotions - where medicines are prescribed for illnesses for which they have not been licensed - and kickbacks to doctors and pharmacists covering several drugs including the
anti-psychotic Risperdal. It is the third largest pharmaceutical-related settlement in US history after GSK's 2012 fine of $3bn and a $2.3bn deal with Pfizer in 2009. Johnson & Johnson also agreed to submit itself to a five-year "corporate integrity" agreement, allowing the Department
of Health & Social Services to scrutinise its ongoing business operations to ensure no further contravention.
Adbrands Weekly Update
31st Oct 2013:
Alison Lewis, who resigned last week from her role as CMO at Coca-Cola North
America, revealed that she has accepted the job of global chief marketing
officer for Johnson & Johnson consumer companies, overseeing marketing for a
huge range of products from Band-aid and Listerine to Neutrogena and Tylenol.
Adbrands.net and access the profile and website links
Adbrands.net. All rights reserved ©
Mind Advertising Ltd 1998-2014